Stephen Parker
Chairman at BIODEXA PHARMACEUTICALS PLC
Net worth: 35 271 $ as of 30/04/2024
Network origin in Stephen Parker first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Miscellaneous Commercial Services | 30 | |
| Public Company | Pharmaceuticals: Other | 21 | |
| Public Company | Pharmaceuticals: Major | 10 | |
Celtic Pharma Management LP
 Celtic Pharma Management LP Investment ManagersFinance Celtic Pharma Management LP is a private equity firm founded by Stephen Evans Freke and John Mayo in 2004. The firm headquartered in Bermuda.
7
| Private Company | Investment Managers | 7 |
| Public Company | Miscellaneous | 6 | |
Drishti Discoveries Ltd.
 Drishti Discoveries Ltd. BiotechnologyHealth Technology Drishti Discoveries Ltd. is a British company founded in 2019 that aims to develop a gene therapy that provides a long-term knockdown of target gene expression. Drishti Discoveries is based in Cambridge, UK. The company uses technology to achieve this goal. The company's website uses cookies to improve user experience while navigating through the website. The website also uses third-party cookies to analyze and understand how users interact with the website. Necessary cookies are used to ensure basic functionalities and security features of the website. Functional cookies are used to perform certain functionalities like sharing the content of the website on social media platforms, collect feedback, and other third-party features.
3
| Holding Company | Biotechnology | 3 |
| Public Company | Miscellaneous Commercial Services | 3 | |
Sareum Ltd.
 Sareum Ltd. Drugstore ChainsRetail Trade Sareum Ltd. provides drug discovery services for treatment of cancer. The company develops robust pipeline of novel small molecule cancer drug candidates for partnering with pharmaceutical companies. Sareum is headquartered in Cambridge, UK
2
| Subsidiary | Drugstore Chains | 2 |
Oxford GlycoSciences Plc
 Oxford GlycoSciences Plc Pharmaceuticals: MajorHealth Technology Oxford Glycosciences Plc provides biopharmaceutical products. The company develops and manufactures novel products for the diagnosis and treatment of human disease. Its products include bayer, pioneer hi-breddupont, medarex, genmab, glaxosmithkline, neogenesis and pfizer. It was founded in 1988. The company is headquartered in Abingdon, UK.
2
| Extinct | Pharmaceuticals: Major | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Stephen Parker via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| University of Cambridge | College/University | Corporate Officer/Principal Doctorate Degree Graduate Degree Doctorate Degree Graduate Degree | |
Auven Therapeutics Management LLLP
 Auven Therapeutics Management LLLP Investment ManagersFinance Founded in 2007 by Stephen Evans-Freke and Peter Corr, Auven Therapeutics Management LLLP is a global private equity firm located in St. Thomas, Virgin Islands. They also have operations in New York City and Europe. The firm was formerly known as Celtic Therapeutics Management, which was the successor firm to Celtic Pharma Management LP. | Investment Managers | Private Equity Investor Founder Director of Finance/CFO Corporate Officer/Principal | |
| University College London | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree Graduate Degree | |
| E-THERAPEUTICS PLC | Biotechnology | Chairman Chief Executive Officer Chief Operating Officer Corporate Officer/Principal | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Chief Tech/Sci/R&D Officer | |
| RENEURON GROUP PLC | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
Governance Institute of Australia Ltd.
 Governance Institute of Australia Ltd. Miscellaneous Commercial ServicesCommercial Services Governance Institute of Australia Ltd. provides education, support, and networking opportunities for directors, Australian company secretaries, governance advisers, and risk managers. The private company is based in Sydney, Australia. Megan Motto has been the CEO of the company since 2019. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| GRAFT POLYMER (UK) PLC | Miscellaneous Manufacturing | Founder Director of Finance/CFO | |
| PREMIER VETERINARY GROUP PLC | Agricultural Commodities/Milling | Chairman Comptroller/Controller/Auditor | |
The Institute of Directors (United Kingdom)
 The Institute of Directors (United Kingdom) Miscellaneous Commercial ServicesCommercial Services The Institute of Directors (United Kingdom) is a community of passionate UK business leaders. The non-profit company is based in Birmingham, UK, and has subsidiaries in the United Kingdom. The British company provides professional training opportunities and access to essential help and resources for its members. The CEO of the company is Stephen Martin. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Midatech Pharma (Wales) Ltd.
 Midatech Pharma (Wales) Ltd. Pharmaceuticals: MajorHealth Technology Midatech Pharma (Wales) Ltd. develops advanced life science and therapeutic products. The company was founded on October 10, 2003 and is headquartered in Cardiff, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| MORPHOSYS AG | Biotechnology | Director of Finance/CFO Corporate Officer/Principal | |
Australian Institute of Co. Directors
 Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Australian Institute of Co. Directors is a non-profit organization that provides leadership on director issues. It offers governance education, director development, and advocacy. The organization was founded in January 1, 1990 and is headquartered in Sydney, Australia. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| Imperial College London | College/University | Doctorate Degree Doctorate Degree | |
Lonza Biologics Plc
 Lonza Biologics Plc Miscellaneous Commercial ServicesCommercial Services Lonza Biologics Plc manufactures monoclonal antibodies, recombinant proteins and diagnostic monoclonal antibodies. The company was founded in 1897 and is headquartered in Slough, the United Kingdom. | Miscellaneous Commercial Services | Chief Executive Officer Chief Executive Officer | |
| The University of Edinburgh | College/University | Undergraduate Degree Undergraduate Degree | |
| University of London | College/University | Undergraduate Degree Doctorate Degree | |
Celtic Pharma Development UK Plc
 Celtic Pharma Development UK Plc Financial ConglomeratesFinance Celtic Pharma Development UK Plc provides financial management services. The company was founded in 2005 and is located in London, GB | Financial Conglomerates | Founder Director/Board Member | |
| TMK ENERGY LIMITED | Oil & Gas Production | Chairman Corporate Secretary | |
| PHARNEXT SCA | Biotechnology | Chief Executive Officer Director of Finance/CFO | |
| BENEVOLENTAI | Biotechnology | Corporate Officer/Principal Director of Finance/CFO | |
Kyowa Kirin International Plc
 Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| DIGITALX LIMITED | Packaged Software | Director/Board Member Corporate Secretary | |
| AUSCANN GROUP HOLDINGS LTD | Agricultural Commodities/Milling | Director/Board Member Chief Executive Officer | |
| SKY AND SPACE COMPANY LTD | Oil & Gas Production | Director/Board Member Corporate Secretary | |
| Georgetown University | College/University | Doctorate Degree Undergraduate Degree | |
| ONCIMMUNE HOLDINGS PLC | Biotechnology | Chief Executive Officer Director/Board Member | |
| SENSYNE HEALTH PLC | Miscellaneous Commercial Services | Corporate Officer/Principal Chairman | |
| ERGOMED | Miscellaneous Commercial Services | Chairman Chief Executive Officer | |
| MEDIGENE AG | Biotechnology | Director of Finance/CFO Corporate Officer/Principal | |
| DELTA LITHIUM LIMITED | Other Metals/Minerals | Chairman Director of Finance/CFO | |
Midatech Ltd.
 Midatech Ltd. BiotechnologyHealth Technology Midatech Ltd. engages in research and experimental development on biotechnology services. The company is headquartered in Abingdon, the United Kingdom. | Biotechnology | Director/Board Member Director/Board Member | |
Cambridge Discovery Chemistry
 Cambridge Discovery Chemistry Miscellaneous Commercial ServicesCommercial Services Part of Signature BioScience, Inc., Cambridge Discovery Chemistry provides chemistry research services. Cambridge Discovery Chemistry was acquired by Signature BioScience, Inc. from Millennium Pharmaceuticals, Inc. on July 16, 2001. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Cristal Delivery BV
 Cristal Delivery BV Pharmaceuticals: MajorHealth Technology Cristal Delivery BV develops and manufactures nanomedicines for therapeutic drug optimization. It offers pipeline, oncology, and inflammation programs. The company was founded by Joost J. M. Holthuis and Cristianne Rijcken in April 2011 and is headquartered in Maastricht, the Netherlands. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| FEEDBACK PLC | Packaged Software | Chairman Director/Board Member | |
| LION ENERGY LIMITED | Oil & Gas Production | Corporate Secretary Corporate Secretary | |
The Bioindustry Association
 The Bioindustry Association Miscellaneous Commercial ServicesCommercial Services The BioIndustry Association is a UK-based organization that represents the life sciences and biotech industry. The British company's mission is to facilitate and connect the ecosystem to help businesses start, grow, and deliver world-changing innovation. The non-profit company was founded by Cormac G. Kilty and Simon Geoffrey Best, and Steve Bates has been the CEO of the company since 2012. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Proteros biostructures GmbH
 Proteros biostructures GmbH Medical/Nursing ServicesHealth Services Proteros biostructures GmbH is a holding company which serves as a discovery service business. Its business areas are Discovery Pipeline, Discovery Services and Science & Technology. The Discovery Pipeline focuses on protein biochemistry, X-ray crystallography, biophysics, computational chemistry and property driven medicinal chemistry, Discovery Services offers drug discovery services with expertise and proprietary technologies for protein production, protein structure analysis, kinetic and thermodynamic profiling and Science & Technology segment focuses on industrialized structure-guided lead development infrastructure. The company was founded by Robert Huber and Torsten Neuefeind in 1999 and is headquartered in Martinsried, Germany. | Medical/Nursing Services | Director of Finance/CFO Chief Executive Officer | |
| ROCHE HOLDING AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| SPARC TECHNOLOGIES LIMITED | Miscellaneous Commercial Services | Director/Board Member Corporate Secretary | |
Kymab Ltd.
 Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Chief Executive Officer Founder | |
| The University of Manchester | College/University | Undergraduate Degree Doctorate Degree | |
| University of Oxford | College/University | Doctorate Degree Undergraduate Degree |
Statistics
International
| United Kingdom | 26 |
| Australia | 10 |
| United States | 8 |
| Germany | 4 |
| Denmark | 2 |
Sectoral
| Health Technology | 19 |
| Consumer Services | 10 |
| Commercial Services | 10 |
| Finance | 5 |
| Energy Minerals | 4 |
Operational
| Director/Board Member | 339 |
| Corporate Officer/Principal | 140 |
| Chairman | 116 |
| Chief Executive Officer | 72 |
| Independent Dir/Board Member | 66 |
Most connected contacts
| Insiders | |
|---|---|
| Annalisa Jenkins | 51 |
| Andrew Richards | 44 |
| Iain Ross | 41 |
| Stephen Evans-Freke | 34 |
| James Ede-Golightly | 29 |
| David Ebsworth | 26 |
| Stuart J. M. Collinson | 25 |
| Alastair Riddell | 24 |
| David Solomon | 22 |
| Brett Mitchell | 22 |
| David Lemus | 22 |
| Paul Harper | 20 |
| Michael Owen | 20 |
| Simon Sturge | 20 |
| John Charles Mayo | 19 |
- Stock Market
- Insiders
- Stephen Parker
- Company connections
